Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2025 Earnings Call Transcript

Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2025 Earnings Call Transcript August 14, 2025

Co-Diagnostics, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.25.

Operator: [Audio Gap] [Operator Instructions]. I’d like to turn the conference over to Andrew Benson, Head of Investor Relations. Andrew, please go ahead.

Andrew Benson: Good afternoon, everyone. Thank you all for participating in today’s conference call. On the line today from Co-Diagnostics, we have Dwight...